Smart technology for clinical decisions
With the deluge of patient information to process, novel diagnostic and therapeutic interventions to consider, clinical guidelines and pathways to follow, and payer conditions to contend with, oncologists and their care teams face a spectrum of clinical and administrative challenges—and with much at stake. The need for cost-effective, personalized care for patients is intensifying, and practices themselves are experiencing the weight of shrinking reimbursement, increased competition, and greater documentation and quality reporting demands.
Amidst this complexity and pressure, smart information technology promises to lend a hand.
Introducing Proventys CDS Oncology™
powered by NCCN®
Proventys has teamed up the National Comprehensive Cancer Network® (NCCN®) the global leader in oncology clinical practice guidelines, to create a first-of-its kind dynamic, web-based decision support platform. CDS Oncology interfaces smoothly with existing EMR/EHR or other point-of-care systems, and features clinical guidelines, customizable pathways, and optional order entry capabilities—all to help practices deliver a higher standard of cost-effective, personalized care.
Click below for enlarged full screens
What makes CDS Oncology stand out:
Delivers the standard of care by exclusively providing the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) dynamically through a prompt-based system at the point-of-care.
Provides actionable and prospective options by helping practices with everyday clinical decisions for patients within the normal workflow.
Individualizes treatment choices and optimizes care by incorporating patient-specific data—lab values, genomic tests, and other information.
Serves as a portal for pathways and quality programs by delivering key information along with NCCN Guidelines™ and facilitating data collection and reporting.
Covers the full continuum of care by offering comprehensive clinical guidance, including optional, easy-to-use order entry functionality.
Provides critical updates to the NCCN Guidelines on a real-time basis—and soon will identify patients to which these updates apply.